⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 6 March, 2025    By - Dr Clemens
ASCs’ cost crisis: How ‘misaligned incentives’ are shaping the industry

Autor: Patsy Newitt Becker’s ASC Review Rising healthcare costs and restrictive policies are creating significant challenges for ASCs, potentially threatening their ability to provide cost-effective, high-quality care. Joe Peluso, administrator at Aestique Surgical Center in Greensburg, Pa., joined Becker’s to discuss his perspective on the policy changes needed to drive sustainability and improve patient access for ASCs. […]

Read More
Uncategorized Published - 5 March, 2025    By - Dr Clemens
Association Between Glycemic Variability and Persistent Acute Kidney Injury After Noncardiac Major Surgery

AUTHORS: Kong, Siyu BS et al  Anesthesia & Analgesia 140(3):p 636-645, March 2025. BACKGROUND: While the relationship between glycemic variability (GV) and acute kidney injury (AKI) has been a subject of interest, the specific association of GV with persistent AKI beyond 48 hours postoperative after noncardiac surgery is not well-established. METHODS: This retrospective cohort study aimed […]

Read More
Uncategorized Published - 5 March, 2025    By - Dr Clemens
A Randomized, Controlled Trial of Palonosetron Versus Ondansetron for Nausea, Vomiting, and Pruritus in Cesarean Delivery with Intrathecal Morphine

AUTHORS: Worravitudomsuk, Tarvit MD et al Anesthesia & Analgesia 140(3):p 628-635, March 2025. BACKGROUND: Spinal anesthesia is the preferred anesthetic technique for cesarean deliveries. Postoperative nausea and vomiting (PONV) and pruritus occur in up to 80% and 83% of patients, respectively, after cesarean delivery with intrathecal opioids. Ondansetron is the recommended medication for PONV prophylaxis, but […]

Read More
Uncategorized Published - 5 March, 2025    By - Dr Clemens
Impact of Sugammadex Versus Neostigmine Reversal on Postoperative Recovery Time in Patients With Obstructive Sleep Apnea Undergoing Bariatric Surgery

AUTHORS: Ajetunmobi, Olawale MB, BS, DA, FCAI et al  Anesthesia & Analgesia 140(3):p 568-576, March 2025. BACKGROUND: Residual neuromuscular blockade can be associated with serious postoperative complications. Sugammadex is a newer neuromuscular blocking drug (NMBD) reversal agent that rapidly and completely reverses rocuronium. Whether sugammadex has any advantages over neostigmine in morbidly obese patients with obstructive […]

Read More
Uncategorized Published - 5 March, 2025    By - Dr Clemens
Editorial: Euglycemic Ketoacidosis Concerns in Perioperative Use of SGLT2 Inhibitors: Re-Examining Current Recommendations

Authors: Soyun M. Hwang, MD; Arney S. Abcejo, MD; Adam K Jacob, MD; Jesse M. Raiten, MD; Manpreet S. Mundi, MD Anesthesia Patient Safety Foundation Volume 40, No. 1 • February 2025  Over the past decade, sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been well established as excellent therapeutic agents for the management of type 2 diabetes mellitus […]

Read More